Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€10.20
16.11.21
€11.00
31.12.24
0.98%
28.06.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.10
13.06.22
€1.00
13.06.23
7.81%
25.06.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€1.43
02.05.22
€1.00
02.05.23
18.02%
05.05.22

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€1.10
27.01.22
€1.00
27.01.23
41.00%
05.02.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€0.99
30.11.21
€1.00
30.11.22
36.36%
11.12.21

Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
buy
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€4.28
21.10.20
€6.00
04.11.21
348.60%
05.11.21

Could be worthwhile Investment >10% per year
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€13.13
25.08.20
€25.20
04.11.21
120.37%
05.11.21

Could be worthwhile Investment >10% per year
buy
Veracyte Inc.

Start price
Target price
Perf. (%)
€30.20
23.08.20
€45.00
04.11.21
49.01%
05.11.21

Could be worthwhile Investment >10% per year
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€18.68
21.05.20
€30.00
04.11.21
531.06%
05.11.21

Could be worthwhile Investment >10% per year
buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€5.79
17.03.20
€15.00
04.11.21
200.79%
05.11.21

Could be worthwhile Investment >10% per year
buy
Adamas Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.46
17.12.19
€6.00
04.11.21
103.76%
05.11.21

Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€9.73
21.08.19
€5.00
04.11.21
-57.83%
05.11.21

buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€2.78
05.05.19
€4.96
04.11.21
110.42%
05.11.21

buy
Five Prime Therapeutics

Start price
Target price
Perf. (%)
€12.11
03.04.19
€18.04
04.11.21
159.21%
05.11.21

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€3.12
13.07.18
€5.41
04.11.21
74.57%
05.11.21

buy
CASI Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€12.50
23.08.21
€10.00
23.08.22
7.20%
04.09.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Dependend from some customers or products
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€73.80
17.06.21
€50.00
17.06.22
-66.50%
17.08.21

Could be worthwhile Investment >10% per year
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€15.29
08.08.20
€24.00
04.11.21
148.67%
03.06.21

Could be worthwhile Investment >10% per year
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€53.20
24.03.21
€60.00
24.03.22
30.86%
06.04.21

Could be worthwhile Investment >10% per year
buy
Trevena Inc.

Start price
Target price
Perf. (%)
€49.08
04.12.20
€55.00
28.04.21
23.84%
09.02.21

Could be very worthwhile Investment >20% year
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.60
08.09.20
€7.00
21.09.20
46.07%
21.09.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€7.21
16.08.19
€16.00
12.05.20
394.45%
12.05.20

buy
Achillion Pharmaceuticals

Start price
Target price
Perf. (%)
€2.74
02.04.19
€3.61
26.07.19
34.92%
26.07.19